STEPHANIE SMITH: Open Payments
NPI 1518473123 · GRAND JUNCTION, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 44 payments from 7 companies in 2025. Trend: 2023 $224 · 2024 $138 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $421 |
| Teva Pharmaceuticals USA, Inc. | 13 | $233 |
| Alkermes, Inc. | 5 | $122 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: HETLIOZ, AUSTEDO XR, FANAPT, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, VYEPTI, UZEDY.
Industry payments across TN — which companies pay providers there.
